Why Less Diabetes with Blockade of the Renin-Angiotensin System?
Open Access
- 1 March 2005
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 16 (3) , 567-569
- https://doi.org/10.1681/asn.2005010019
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic MiceHypertension, 2004
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Salt Intake, Endothelial Cell Signaling, and Progression of Kidney DiseaseHypertension, 2004
- How Far Should Salt Intake Be Reduced?Hypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Global and societal implications of the diabetes epidemicNature, 2001
- Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of saltKidney International, 1994
- Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditionsJournal Of Hypertension, 1993
- HYPERTENSION AND NEPHRITISThe Lancet Healthy Longevity, 1939